Early percutaneous mitral commissurotomy or conventional management for asymptomatic mitral stenosis: a randomised clinical trial
- 15 September 2021
- Vol. 107 (24), 1980-1986
- https://doi.org/10.1136/heartjnl-2021-319857
Abstract
Objective The decision to perform percutaneous mitral commissurotomy (PMC) on asymptomatic patients requires careful weighing of the potential benefits against the risks of PMC, and we conducted a multicentre, randomised trial to compare long-term outcomes of early PMC and conventional treatment in asymptomatic, severe mitral stenosis (MS). Methods We randomly assigned asymptomatic patients with severe MS (defined as mitral valve area between 1.0 and 1.5 cm2) to early PMC (84 patients) or to conventional treatment (83 patients). The primary endpoint was a composite of major cardiovascular events, including PMC-related complications, cardiovascular mortality, cerebral infarction and systemic thromboembolic events. The secondary endpoints were death from any cause and mitral valve (MV) replacement during follow-up. Results In the early PMC group, there were no PMC-related complications. During the median follow-up of 6.4 years, the composite primary endpoint occurred in seven patients in the early PMC group (8.3%) and in nine patients in the conventional treatment group (10.8%) (HR 0.77; 95% CI 0.29 to 2.07; p=0.61). Death from any cause occurred in four patients in the early PMC group (4.8%) and three patients in the conventional treatment group (3.6%) (HR 1.30; 95% CI 0.29 to 5.77). Ten patients (11.9%) in the early PMC group and 17 patients (20.5%) in the conventional treatment group underwent MV replacement (HR 0.59; 95% CI 0.27 to 1.29). Conclusions Compared with conventional treatment, early PMC did not significantly reduce the incidence of cardiovascular events among asymptomatic patients with severe MS during the median follow-up of 6 years. Trial registration number NCT01406353.Keywords
Funding Information
- Asan Institute for Life Sciences, Asan Medical Center (2011-0432)
This publication has 24 references indexed in Scilit:
- Early percutaneous mitral commissurotomy vs. conventional management in asymptomatic moderate mitral stenosisEuropean Heart Journal, 2012
- Effect of Hydroxymethylglutaryl Coenzyme-A Reductase Inhibitors on the Long-Term Progression of Rheumatic Mitral Valve DiseaseJournal of the American College of Cardiology, 2010
- Long-Term Outcomes of Significant Mitral Regurgitation After Percutaneous Mitral ValvuloplastyJournal of the American College of Cardiology, 2006
- Modern Management of Mitral StenosisJournal of the American College of Cardiology, 2005
- Temporal trends in percutaneous mitral commissurotomy over a 15-year periodEuropean Heart Journal, 2004
- Long-term clinical and echocardiographic outcome of percutaneous mitral valvuloplasty: Randomized comparison of Inoue and double-balloon techniquesJournal of Invasive Cardiology, 2000
- Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: Valve area and right heart diseaseJournal of Invasive Cardiology, 1996
- Prevalence and predictors of atrial fibrillation in rheumatic valvular heart diseaseThe American Journal of Cardiology, 1996
- Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: Implications for follow-upJournal of Invasive Cardiology, 1992
- Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosisEuropean Heart Journal, 1991